https://novapharmanews.com/us/articles/inside-makarys-ouster-lilly-triple-g-success 2026-05-23T21:11:45.682Z daily 0.7 https://novapharmanews.com/us/articles/perimenopause-movement-hurt-women 2026-05-23T21:11:06.224Z daily 0.7 https://novapharmanews.com/us/articles/astrazeneca-daiichi-fda-approval-datroway-tnbc 2026-05-23T23:30:13.927Z daily 0.7 https://novapharmanews.com/us/articles/medicaid-funding-cuts-pharma-providers 2026-05-23T23:29:29.481Z daily 0.7 https://novapharmanews.com/us/articles/designing-future-ready-tech-roadmap-emerging-pharma 2026-05-23T23:29:17.320Z daily 0.7 https://novapharmanews.com/us/articles/astrazeneca-eu-approval-breast-cancer-drug 2026-05-23T23:29:16.306Z daily 0.7 https://novapharmanews.com/us/articles/biogen-denali-parkinsons-drug-trial-failure 2026-05-23T23:20:17.940Z daily 0.7 https://novapharmanews.com/us/articles/tender-offer-recordati-sobi-gout-drug-phase-3 2026-05-23T22:53:34.120Z daily 0.7 https://novapharmanews.com/us/articles/gop-lawmaker-china-biotech-deals 2026-05-23T22:29:14.547Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-datroway-breast-cancer 2026-05-23T21:59:15.607Z daily 0.7 https://novapharmanews.com/eu/articles/abbvie-layoffs-allergan-aesthetics 2026-05-23T21:41:02.264Z daily 0.7 https://novapharmanews.com/eu/articles/tyra-awareness-day-rare-cancer 2026-05-23T21:41:01.729Z daily 0.7 https://novapharmanews.com/us/articles/astrazeneca-breast-cancer-drug-chmp-approval-fda-rejection 2026-05-23T21:29:04.554Z daily 0.7 https://novapharmanews.com/apac/articles/abbvie-gsk-patient-reputation-uk 2026-05-23T21:11:18.649Z daily 0.7 https://novapharmanews.com/us/articles/asco26-data-snapshots-cancer-drug-meeting 2026-05-23T23:20:33.022Z daily 0.7 https://novapharmanews.com/us/articles/abbvie-gsk-patient-reputation-uk 2026-05-23T23:20:12.945Z daily 0.7 https://novapharmanews.com/us/articles/novartis-abbvie-layoffs-pharma-industry 2026-05-23T23:20:07.714Z daily 0.7 https://novapharmanews.com/us/articles/fda-approves-first-treatment-hdv-infection 2026-05-23T23:19:50.074Z daily 0.7 https://novapharmanews.com/us/articles/fda-approves-gilead-hepatitis-d-drug 2026-05-23T23:19:49.611Z daily 0.7 https://novapharmanews.com/us/articles/utahs-ai-prescribing-experiment-progress-insights 2026-05-23T23:19:44.248Z daily 0.7 https://novapharmanews.com/us/articles/five-key-regulatory-updates-asco 2026-05-23T22:37:00.487Z daily 0.7 https://novapharmanews.com/us/articles/palvella-secures-230m-qtorin-rare-diseases 2026-05-23T22:34:54.369Z daily 0.7 https://novapharmanews.com/apac/articles/merck-trofuse-005-trial-results 2026-05-23T21:10:37.447Z daily 0.7 https://novapharmanews.com/us/articles/bio-2026-preview 2026-05-23T23:19:31.982Z daily 0.7 https://novapharmanews.com/us/articles/bio-2026-event-preview 2026-05-23T23:19:31.382Z daily 0.7 https://novapharmanews.com/eu/articles/euroocs-annual-meeting-2026-preview 2026-05-23T21:41:02.577Z daily 0.7 https://novapharmanews.com/us/articles/resi-san-diego-2026-preview 2026-05-23T23:19:43.804Z daily 0.7 https://novapharmanews.com/us/articles/health-ai-unicorn-free-services 2026-05-23T23:28:30.512Z daily 0.7 https://novapharmanews.com/us/articles/genentech-pharma-reforms-strategy 2026-05-23T23:12:17.468Z daily 0.7 https://novapharmanews.com/us/articles/ai-doctor-office-check-ins 2026-05-23T23:10:51.357Z daily 0.7 https://novapharmanews.com/us/articles/parkinsons-drug-setback-merck-lung-cancer-therapy 2026-05-23T22:57:04.515Z daily 0.7 https://novapharmanews.com/us/articles/seed-oil-panic-cardiac-health 2026-05-23T22:42:18.066Z daily 0.7 https://novapharmanews.com/us/articles/merck-kelun-adc-strategic-wins-takeda-antitrust-loss 2026-05-23T22:42:02.960Z daily 0.7 https://novapharmanews.com/us/articles/cdc-mpox-page-political-crosshairs 2026-05-23T22:28:15.781Z daily 0.7 https://novapharmanews.com/us/articles/ibrance-heirs-gileads-tubulis-data-asco26 2026-05-23T22:27:15.885Z daily 0.7 https://novapharmanews.com/us/articles/retro-biosciences-1-8-billion-fundraising 2026-05-23T22:16:24.143Z daily 0.7 https://novapharmanews.com/us/articles/biogen-denali-parkinsons-drug-study-setback 2026-05-23T22:12:14.832Z daily 0.7 https://novapharmanews.com/us/articles/novartis-avidity-science-beyond-muscular-dystrophies 2026-05-23T22:12:10.004Z daily 0.7 https://novapharmanews.com/us/articles/federal-office-mens-health-horizon 2026-05-23T21:42:05.742Z daily 0.7 https://novapharmanews.com/us/articles/leadership-changes-amgen-zai-lab 2026-05-23T20:42:26.491Z daily 0.7 https://novapharmanews.com/us/articles/eu-us-split-astra-zeneca-breast-cancer-drug 2026-05-23T19:57:08.968Z daily 0.7 https://novapharmanews.com/us/articles/senators-grill-nih-director-key-insights-for-pharma 2026-05-23T21:47:45.757Z daily 0.7 https://novapharmanews.com/us/articles/merck-kelun-lung-cancer-drug-tumor-progression-risk 2026-05-23T17:55:12.924Z daily 0.7 https://novapharmanews.com/us/articles/asco26-kelun-phase-3-lung-cancer-success 2026-05-23T17:36:07.737Z daily 0.7 https://novapharmanews.com/us/articles/asco26-head-neck-cancer-developments 2026-05-23T14:05:30.903Z daily 0.7 https://novapharmanews.com/us/articles/stat-parkinsons-drug-fails-key-trial 2026-05-23T23:30:33.592Z daily 0.7 https://novapharmanews.com/us/articles/first-ras-inhibitor-extends-survival-metastatic-pancreatic-cancer 2026-05-23T23:27:32.571Z daily 0.7 https://novapharmanews.com/apac/articles/kelun-biotech-skb118-approval 2026-05-23T23:11:03.472Z daily 0.7 https://novapharmanews.com/eu/articles/roche-elevidys-eu-approval-update 2026-05-23T20:27:14.329Z daily 0.7 https://novapharmanews.com/us/articles/asco26-vegf-bispecifics-biontech-bms-pfizer-3sbio 2026-05-23T19:13:43.263Z daily 0.7 https://novapharmanews.com/us/articles/roche-astra-zeneca-oncology-msl-team-survey 2026-05-23T18:02:09.380Z daily 0.7 https://novapharmanews.com/us/articles/merck-kelun-adc-combo-keytruda-lung-cancer 2026-05-23T14:42:16.994Z daily 0.7 https://novapharmanews.com/us/articles/mass-general-brigham-saving-lives-doctors-concerns 2026-05-23T04:59:19.754Z daily 0.7 https://novapharmanews.com/eu/articles/ogilvy-health-ai-nano-influencers 2026-05-23T22:41:59.248Z daily 0.7 https://novapharmanews.com/us/articles/rfk-jr-screen-time-warning-pharma 2026-05-23T22:27:52.614Z daily 0.7 https://novapharmanews.com/us/articles/ra-capital-biotech-spac-75m 2026-05-23T21:45:45.260Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-fraud-allegations-trulicity 2026-05-23T21:25:23.024Z daily 0.7 https://novapharmanews.com/us/articles/biotechs-covert-campaign-fda-commissioner 2026-05-23T20:27:39.131Z daily 0.7 https://novapharmanews.com/us/articles/immunovant-shares-surge-arthritis-trial-data 2026-05-23T19:00:22.111Z daily 0.7 https://novapharmanews.com/us/articles/guarding-biotech-from-china-big-bets-longevity 2026-05-23T05:43:01.581Z daily 0.7 https://novapharmanews.com/us/articles/gilead-ambiosome-visceral-leishmaniasis 2026-05-23T23:30:29.888Z daily 0.7 https://novapharmanews.com/us/articles/lilly-triple-acting-obesity-drug-phase-3-trial 2026-05-23T22:46:03.592Z daily 0.7 https://novapharmanews.com/us/articles/nih-infectious-disease-institute-leadership-change 2026-05-23T22:27:19.304Z daily 0.7 https://novapharmanews.com/us/articles/biomarin-voxzogo-label-expansion 2026-05-23T21:58:45.015Z daily 0.7 https://novapharmanews.com/us/articles/amgen-tavneos-label-update-japan 2026-05-23T20:57:09.972Z daily 0.7 https://novapharmanews.com/us/articles/florida-hospitals-medicaid-funds-strategic-overview 2026-05-23T18:58:02.252Z daily 0.7 https://novapharmanews.com/us/articles/bms-expansion-texas-novartis-tenant-eviction 2026-05-23T18:56:45.582Z daily 0.7 https://novapharmanews.com/us/articles/elevance-executive-testifies-medicare-advantage-fraud 2026-05-23T18:51:51.734Z daily 0.7 https://novapharmanews.com/us/articles/lilly-obesity-drug-trial-alzheimers-statistics 2026-05-23T17:14:23.190Z daily 0.7 https://novapharmanews.com/us/articles/big-pharma-q1-growth-insights 2026-05-23T17:01:29.124Z daily 0.7 https://novapharmanews.com/us/articles/senate-nih-director-2027-budget 2026-05-23T15:46:43.397Z daily 0.7 https://novapharmanews.com/us/articles/biomarin-approval-voxzogo-short-stature 2026-05-23T14:24:57.879Z daily 0.7 https://novapharmanews.com/us/articles/biomarin-study-success-expansion 2026-05-23T07:27:01.358Z daily 0.7 https://novapharmanews.com/us/articles/incyte-signs-ai-deals-genesis-edison 2026-05-23T05:38:31.955Z daily 0.7 https://novapharmanews.com/us/articles/chinas-drugmakers-asco26 2026-05-23T05:00:03.793Z daily 0.7 https://novapharmanews.com/us/articles/bristol-myers-alzheimers-promise-beyond-amyloid 2026-05-23T04:59:55.743Z daily 0.7 https://novapharmanews.com/eu/articles/cg-life-collette-douaihy-appointment 2026-05-23T23:18:58.836Z daily 0.7 https://novapharmanews.com/eu/articles/tarsus-john-cena-demodex-blepharitis-campaign 2026-05-23T22:53:13.053Z daily 0.7 https://novapharmanews.com/eu/articles/gilead-yuhan-140m-deal 2026-05-23T22:32:29.303Z daily 0.7 https://novapharmanews.com/eu/articles/immunitybio-anktiva-fda-decision-date 2026-05-23T21:41:01.918Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-triple-g-drug-weight-loss-trial 2026-05-23T19:56:47.542Z daily 0.7 https://novapharmanews.com/us/articles/ai-co-scientist-tools-useful 2026-05-23T19:06:18.613Z daily 0.7 https://novapharmanews.com/eu/articles/amgen-cfo-transition-galderma-exec 2026-05-23T17:54:25.287Z daily 0.7 https://novapharmanews.com/eu/articles/ucb-bimzelx-skyrizi-psoriatic-arthritis-win 2026-05-23T17:44:16.348Z daily 0.7 https://novapharmanews.com/us/articles/whoop-fda-blood-pressure-feature-discussions 2026-05-23T17:09:07.389Z daily 0.7 https://novapharmanews.com/eu/articles/beone-one-save-changes-everything-campaign-tim-howard 2026-05-23T15:56:30.377Z daily 0.7 https://novapharmanews.com/eu/articles/roche-xofluza-licensing-deal 2026-05-23T13:21:07.015Z daily 0.7 https://novapharmanews.com/us/articles/dark-times-ahead-at-the-fda 2026-05-23T08:28:11.125Z daily 0.7 https://novapharmanews.com/us/articles/long-term-medical-consequences-bullet-fragments 2026-05-23T07:42:35.433Z daily 0.7 https://novapharmanews.com/us/articles/lilly-triple-agonist-obesity-assets 2026-05-23T06:27:36.061Z daily 0.7 https://novapharmanews.com/eu/articles/ipsen-transition-adult-care 2026-05-23T05:41:52.157Z daily 0.7 https://novapharmanews.com/eu/articles/germany-bioeconomy-dialogue-pharma-implications 2026-05-23T10:02:59.163Z daily 0.7 https://novapharmanews.com/us/articles/ucb-bimzelx-vs-abbvie-skyrizi-competitive-analysis 2026-05-23T21:33:02.373Z daily 0.7 https://novapharmanews.com/us/articles/fda-warning-illegal-tobacco-products 2026-05-23T18:42:17.479Z daily 0.7 https://novapharmanews.com/us/articles/parabilis-ipo-plans-regeneron-deal 2026-05-23T16:51:05.766Z daily 0.7 https://novapharmanews.com/us/articles/kennedy-interim-surgeon-general-pharma-implications 2026-05-23T15:50:12.392Z daily 0.7 https://novapharmanews.com/us/articles/pfizers-next-gen-pneumonia-shot-prevnar-20 2026-05-23T15:28:55.751Z daily 0.7 https://novapharmanews.com/us/articles/dcat-week-2024-preview 2026-05-23T05:00:57.827Z daily 0.7 https://novapharmanews.com/us/articles/beone-one-save-changes-everything-campaign 2026-05-23T23:24:12.593Z daily 0.7 https://novapharmanews.com/us/articles/ipsen-transition-challenges-pharma-teams 2026-05-23T21:38:54.456Z daily 0.7 https://novapharmanews.com/us/articles/oorja-launches-new-fibrosis-drugs 2026-05-23T21:36:39.671Z daily 0.7 https://novapharmanews.com/us/articles/kennedy-leadership-shakeup-preventive-services 2026-05-23T20:57:03.138Z daily 0.7 https://novapharmanews.com/us/articles/gho-capital-cbc-group-merger-healthcare-investment 2026-05-23T20:24:28.986Z daily 0.7 https://novapharmanews.com/us/articles/surgeon-general-warning-screen-time-children 2026-05-23T20:18:52.550Z daily 0.7 https://novapharmanews.com/us/articles/impact-fda-turnover-rare-disease-drug-development 2026-05-23T20:02:36.363Z daily 0.7 https://novapharmanews.com/us/articles/ebola-doctor-patient-perspective 2026-05-23T20:01:50.926Z daily 0.7 https://novapharmanews.com/us/articles/gilead-yuhan-deal-tracker 2026-05-23T19:56:33.050Z daily 0.7 https://novapharmanews.com/us/articles/glp-1s-pharma-consumer-relationships 2026-05-23T19:36:56.603Z daily 0.7 https://novapharmanews.com/us/articles/amgen-cfo-transition-galderma-exec 2026-05-23T19:23:51.751Z daily 0.7 https://novapharmanews.com/us/articles/fetal-gene-therapy-embryo-editing-taboo 2026-05-23T19:17:30.939Z daily 0.7 https://novapharmanews.com/us/articles/bristol-myers-anthropic-ai-investment 2026-05-23T19:00:45.947Z daily 0.7 https://novapharmanews.com/us/articles/immunitybio-anktiva-fda-decision-date 2026-05-23T18:20:15.159Z daily 0.7 https://novapharmanews.com/us/articles/tracking-cellular-disruptions-type-1-diabetes 2026-05-23T13:58:32.398Z daily 0.7 https://novapharmanews.com/us/articles/immunovant-autoimmune-blockbuster-wave-rna-editing 2026-05-23T13:36:18.174Z daily 0.7 https://novapharmanews.com/us/articles/ii-biotech-campfield-180m-series-a-funding 2026-05-23T09:44:38.394Z daily 0.7 https://novapharmanews.com/us/articles/parabilis-ipo-undruggable-targets 2026-05-23T08:34:30.963Z daily 0.7 https://novapharmanews.com/us/articles/bms-anthropic-ai-adoption 2026-05-23T07:13:14.914Z daily 0.7 https://novapharmanews.com/us/articles/tarsus-john-cena-demodex-blepharitis-campaign 2026-05-23T05:43:43.415Z daily 0.7 https://novapharmanews.com/us/articles/ucb-bimzelx-skyrizi-psoriatic-arthritis 2026-05-23T22:30:09.662Z daily 0.7 https://novapharmanews.com/us/articles/pharma-manufacturing-world-2026-coverage 2026-05-23T22:04:27.150Z daily 0.7 https://novapharmanews.com/us/articles/trumprx-adds-generic-medicines 2026-05-23T20:44:50.332Z daily 0.7 https://novapharmanews.com/us/articles/paragon-reverse-merger-migraine-drugs 2026-05-23T20:20:43.118Z daily 0.7 https://novapharmanews.com/us/articles/bbsw-ai-solution-2026-event-coverage 2026-05-23T20:18:16.964Z daily 0.7 https://novapharmanews.com/apac/articles/merck-kelun-trop2-regulatory-updates 2026-05-23T19:20:28.854Z daily 0.7 https://novapharmanews.com/us/articles/atara-bounces-back-fda-oncology 2026-05-23T19:20:07.079Z daily 0.7 https://novapharmanews.com/us/articles/asgct-annual-meeting-2026-coverage 2026-05-23T15:35:19.816Z daily 0.7 https://novapharmanews.com/us/articles/acceleron-westlake-ipf-biotech-launch 2026-05-23T15:18:58.457Z daily 0.7 https://novapharmanews.com/us/articles/regulatory-education-2026 2026-05-23T09:23:14.880Z daily 0.7 https://novapharmanews.com/us/articles/redi-2026-conference-coverage 2026-05-23T23:06:43.976Z daily 0.7 https://novapharmanews.com/us/articles/drugmakers-ip-protections-china-competition 2026-05-23T22:58:01.410Z daily 0.7 https://novapharmanews.com/us/articles/migraine-drugmaker-reverse-merger 2026-05-23T21:58:51.561Z daily 0.7 https://novapharmanews.com/us/articles/white-house-trumprx-portal-expansion 2026-05-23T21:51:19.694Z daily 0.7 https://novapharmanews.com/us/articles/gilead-yuhan-140m-deal 2026-05-23T21:25:12.297Z daily 0.7 https://novapharmanews.com/us/articles/navigating-the-data-2026 2026-05-23T19:08:01.079Z daily 0.7 https://novapharmanews.com/eu/articles/pharma-partnering-eu-2026-coverage 2026-05-23T10:03:30.876Z daily 0.7 https://novapharmanews.com/us/articles/florida-hospitals-8-billion-medicaid-funds 2026-05-23T22:38:49.050Z daily 0.7 https://novapharmanews.com/us/articles/fda-warns-illegal-tobacco-products 2026-05-23T21:36:43.668Z daily 0.7 https://novapharmanews.com/us/articles/ii-biotech-campfield-180m-series-a-investment 2026-05-23T21:06:08.743Z daily 0.7 https://novapharmanews.com/us/articles/cg-life-collette-douaihy-cco-appointment 2026-05-23T20:36:58.257Z daily 0.7 https://novapharmanews.com/us/articles/roche-xofluza-licensing-deal 2026-05-23T18:13:32.672Z daily 0.7 https://novapharmanews.com/us/articles/stat-pioneering-trial-genetic-disease 2026-05-23T15:51:14.493Z daily 0.7 https://novapharmanews.com/us/articles/kennedy-fires-leaders-preventive-services-task-force 2026-05-23T15:02:19.233Z daily 0.7 https://novapharmanews.com/us/articles/cg-life-collette-douaihy-appointment 2026-05-23T14:37:02.930Z daily 0.7 https://novapharmanews.com/us/articles/congressional-democrats-end-medicare-ai-pilot 2026-05-23T12:43:13.617Z daily 0.7 https://novapharmanews.com/us/articles/oorja-launches-new-fibrosis-drug-development 2026-05-23T08:34:50.953Z daily 0.7 https://novapharmanews.com/us/articles/clinical-research-patient-2026 2026-05-23T07:12:46.865Z daily 0.7 https://novapharmanews.com/eu/articles/beone-one-save-changes-everything-campaign 2026-05-23T05:18:00.592Z daily 0.7 https://novapharmanews.com/us/articles/redi-2026-conference-event-coverage 2026-05-23T05:02:31.895Z daily 0.7 https://novapharmanews.com/us/articles/palvella-pivotal-rare-disease-data-financial-outlook 2026-05-23T23:29:58.991Z daily 0.7 https://novapharmanews.com/us/articles/leadership-changes-preventive-services-task-force 2026-05-23T22:57:18.954Z daily 0.7 https://novapharmanews.com/apac/articles/amgen-cfo-departure-galderma-strategic-move 2026-05-23T21:54:30.075Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-engage-acquisition-genetic-medicine 2026-05-23T21:36:35.550Z daily 0.7 https://novapharmanews.com/eu/articles/maat-pharma-regulatory-update-maat013-xervyteg 2026-05-23T19:44:51.039Z daily 0.7 https://novapharmanews.com/apac/articles/bms-anthropic-ai-adoption 2026-05-23T17:46:10.746Z daily 0.7 https://novapharmanews.com/eu/articles/ucb-bimzelx-psoriatic-arthritis-skyrizi 2026-05-23T16:22:06.660Z daily 0.7 https://novapharmanews.com/eu/articles/pharma-partnering-eu-2026 2026-05-23T16:16:43.944Z daily 0.7 https://novapharmanews.com/us/articles/ebola-doctor-patient-perspectives 2026-05-23T13:10:39.175Z daily 0.7 https://novapharmanews.com/us/articles/cg-life-appoints-collette-douaihy-chief-creative-officer 2026-05-23T09:08:32.450Z daily 0.7 https://novapharmanews.com/eu/articles/cg-life-appoints-collette-douaihy-cco 2026-05-23T05:08:04.287Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-acquires-engage-genetic-medicine 2026-05-23T23:15:12.241Z daily 0.7 https://novapharmanews.com/us/articles/parabilis-raises-800m-ipo-undruggable-targets 2026-05-23T22:41:40.570Z daily 0.7 https://novapharmanews.com/us/articles/immunovant-wave-autoimmune-innovations 2026-05-23T21:02:57.638Z daily 0.7 https://novapharmanews.com/apac/articles/cg-life-new-chief-creative-officer-implications 2026-05-23T20:22:38.305Z daily 0.7 https://novapharmanews.com/eu/articles/impharma2026-preview 2026-05-23T19:13:35.315Z daily 0.7 https://novapharmanews.com/us/articles/lilly-engage-acquisition-non-viral-genetic-medicines 2026-05-23T18:24:06.774Z daily 0.7 https://novapharmanews.com/apac/articles/logipharma-asia-2026-preview 2026-05-23T11:09:30.715Z daily 0.7 https://novapharmanews.com/us/articles/drug-discovery-usa-2026-preview 2026-05-23T10:04:38.855Z daily 0.7 https://novapharmanews.com/us/articles/bbsw-ai-solution-2026-coverage 2026-05-23T09:09:41.357Z daily 0.7 https://novapharmanews.com/eu/articles/hlth-europe-2026-preview 2026-05-23T07:45:30.608Z daily 0.7 https://novapharmanews.com/us/articles/marc-tessier-lavigne-responds-allegations-stanford-case 2026-05-23T22:45:54.062Z daily 0.7 https://novapharmanews.com/us/articles/streamlined-rd-novo-nordisk 2026-05-23T22:13:08.956Z daily 0.7 https://novapharmanews.com/us/articles/clinical-research-patient-2026-preview 2026-05-23T21:30:45.411Z daily 0.7 https://novapharmanews.com/us/articles/23andme-connects-dna-data-medical-records 2026-05-23T21:30:23.664Z daily 0.7 https://novapharmanews.com/us/articles/novartis-terminates-contract-porton-implications 2026-05-23T21:12:57.479Z daily 0.7 https://novapharmanews.com/us/articles/current-landscape-consumer-health 2026-05-23T21:01:45.426Z daily 0.7 https://novapharmanews.com/us/articles/takeda-885m-verdict-pay-delay-antitrust 2026-05-23T13:23:42.919Z daily 0.7 https://novapharmanews.com/us/articles/supreme-court-decision-ira-challenges-pharma 2026-05-23T21:59:21.499Z daily 0.7 https://novapharmanews.com/us/articles/nih-leadership-gaps-pharmaceutical-industry 2026-05-23T21:38:57.231Z daily 0.7 https://novapharmanews.com/us/articles/beone-one-save-changes-everything-campaign-tim-howard 2026-05-23T21:36:27.952Z daily 0.7 https://novapharmanews.com/us/articles/biomarin-drug-acquisition-missed-goals-rare-disease-study 2026-05-23T18:58:00.125Z daily 0.7 https://novapharmanews.com/us/articles/leadership-challenges-at-nih 2026-05-23T15:15:23.546Z daily 0.7 https://novapharmanews.com/us/articles/who-defends-ebola-response-rubio-critique 2026-05-23T13:24:43.719Z daily 0.7 https://novapharmanews.com/us/articles/biotech-investors-mood-fda-insights 2026-05-23T08:41:30.511Z daily 0.7 https://novapharmanews.com/us/articles/state-of-consumer-health-trends-insights 2026-05-23T05:03:51.937Z daily 0.7 https://novapharmanews.com/us/articles/who-defense-ebola-response 2026-05-23T05:03:35.923Z daily 0.7 https://novapharmanews.com/us/articles/kennedy-leadership-shakeup-preventive-services-task-force 2026-05-23T22:26:38.611Z daily 0.7 https://novapharmanews.com/us/articles/next-big-pharma-company-china 2026-05-23T08:34:42.168Z daily 0.7 https://novapharmanews.com/eu/articles/amgen-cfo-departure-galderma-executive 2026-05-23T20:44:00.487Z daily 0.7 https://novapharmanews.com/us/articles/cg-life-c-suite-expansion-collette-douaihy 2026-05-23T20:33:09.625Z daily 0.7 https://novapharmanews.com/us/articles/oorja-launches-new-fibrosis-drugs-acceleron-veterans 2026-05-23T20:10:56.512Z daily 0.7 https://novapharmanews.com/apac/articles/beone-one-save-changes-everything-campaign 2026-05-23T19:31:05.346Z daily 0.7 https://novapharmanews.com/us/articles/amgen-cfo-departure-galderma-exec 2026-05-23T16:31:29.352Z daily 0.7 https://novapharmanews.com/eu/articles/cg-life-appoints-collette-douaihy-chief-creative-officer 2026-05-23T15:11:08.944Z daily 0.7 https://novapharmanews.com/us/articles/openevidence-hospital-pitch 2026-05-23T05:04:09.946Z daily 0.7 https://novapharmanews.com/us/articles/biomarin-rare-disease-therapy-phase-3-trial-failure 2026-05-23T21:58:37.630Z daily 0.7 https://novapharmanews.com/us/articles/relays-pi3ka-inhibitor-phase-2-study 2026-05-23T21:02:07.922Z daily 0.7 https://novapharmanews.com/us/articles/future-uses-cgm-dexcom-ceo-insights 2026-05-23T18:13:57.094Z daily 0.7 https://novapharmanews.com/us/articles/bristol-myers-houston-manufacturing-plant 2026-05-23T16:51:50.579Z daily 0.7 https://novapharmanews.com/us/articles/roche-alecensa-japan-expansion 2026-05-23T13:23:21.030Z daily 0.7 https://novapharmanews.com/eu/articles/bristol-myers-houston-manufacturing-plant 2026-05-23T12:22:22.454Z daily 0.7 https://novapharmanews.com/apac/articles/roche-alecensa-japan-expansion 2026-05-23T11:58:08.900Z daily 0.7 https://novapharmanews.com/us/articles/merck-kelun-sac-tmt-endometrial-cancer-trial 2026-05-23T10:58:43.951Z daily 0.7 https://novapharmanews.com/us/articles/virginia-governor-vetoes-drug-cost-panel 2026-05-23T21:58:16.321Z daily 0.7 https://novapharmanews.com/us/articles/fda-future-david-kessler-insights 2026-05-23T21:38:44.396Z daily 0.7 https://novapharmanews.com/us/articles/ai-treatment-newborn-ultra-rare-disease 2026-05-23T20:13:14.517Z daily 0.7 https://novapharmanews.com/us/articles/trumprx-adds-generic-drugs 2026-05-23T19:51:23.705Z daily 0.7 https://novapharmanews.com/us/articles/regulatory-education-2026-preview 2026-05-23T19:44:22.866Z daily 0.7 https://novapharmanews.com/us/articles/trumps-cuts-foreign-aid-ebola-response 2026-05-23T11:06:44.318Z daily 0.7 https://novapharmanews.com/us/articles/spine-surgery-cost-no-surprises-act 2026-05-23T05:04:27.954Z daily 0.7 https://novapharmanews.com/eu/articles/trumprx-generic-meds-initiative 2026-05-23T22:35:17.209Z daily 0.7 https://novapharmanews.com/us/articles/trump-foreign-aid-cuts-ebola-response 2026-05-23T22:22:43.096Z daily 0.7 https://novapharmanews.com/us/articles/openevidence-pitch-hospitals 2026-05-23T22:13:10.547Z daily 0.7 https://novapharmanews.com/us/articles/supreme-court-ira-ruling-pharma-deals 2026-05-23T21:02:35.413Z daily 0.7 https://novapharmanews.com/us/articles/navigating-the-data-2026-pre-event 2026-05-23T21:01:20.667Z daily 0.7 https://novapharmanews.com/us/articles/rise-of-perimenopause-misinformation 2026-05-23T19:29:45.967Z daily 0.7 https://novapharmanews.com/eu/articles/slas-europe-2026-event-coverage 2026-05-23T17:51:18.130Z daily 0.7 https://novapharmanews.com/us/articles/senate-democrats-long-term-care-benefit-medicare 2026-05-23T14:41:54.615Z daily 0.7 https://novapharmanews.com/us/articles/ai-treatment-ultra-rare-disease-newborns 2026-05-23T12:22:04.820Z daily 0.7 https://novapharmanews.com/eu/articles/astrazeneca-fda-approval-hypertension-fasenra 2026-05-23T10:41:30.926Z daily 0.7 https://novapharmanews.com/us/articles/scope-x-2026-event-coverage 2026-05-23T05:05:02.012Z daily 0.7 https://novapharmanews.com/us/articles/ispor-2026-event-coverage 2026-05-23T05:04:41.965Z daily 0.7 https://novapharmanews.com/us/articles/virginia-governor-vetoes-prescription-drug-costs 2026-05-23T22:43:29.306Z daily 0.7 https://novapharmanews.com/us/articles/impact-600-generic-meds-trumprx-portal 2026-05-23T19:09:39.418Z daily 0.7 https://novapharmanews.com/apac/articles/ucb-bimzelx-psoriatic-arthritis-win 2026-05-23T19:05:37.600Z daily 0.7 https://novapharmanews.com/apac/articles/takeda-885m-verdict-pay-delay-antitrust-case 2026-05-23T16:45:50.438Z daily 0.7 https://novapharmanews.com/eu/articles/novartis-terminates-cdmo-contract-porton 2026-05-23T16:02:48.881Z daily 0.7 https://novapharmanews.com/us/articles/openevidence-pitches-hospitals 2026-05-23T05:05:14.021Z daily 0.7 https://novapharmanews.com/us/articles/biomarin-drug-acquisition-study-setback 2026-05-23T23:15:44.786Z daily 0.7 https://novapharmanews.com/us/articles/no-surprises-act-spine-surgery-costs-skyrocket 2026-05-23T23:02:50.949Z daily 0.7 https://novapharmanews.com/us/articles/marc-tessier-lavigne-responds-allegations 2026-05-23T21:31:45.253Z daily 0.7 https://novapharmanews.com/us/articles/canadian-medical-societies-conflict-of-interest-policies 2026-05-23T17:38:09.278Z daily 0.7 https://novapharmanews.com/us/articles/fda-shakeup-hoeg-fired-amgen-drug-controversy 2026-05-23T16:41:07.306Z daily 0.7 https://novapharmanews.com/us/articles/bio-it-world-conference-2026-live-coverage 2026-05-23T12:08:57.451Z daily 0.7 https://novapharmanews.com/eu/articles/biodefence-biosecurity-europabio-task-force 2026-05-23T09:43:44.228Z daily 0.7 https://novapharmanews.com/us/articles/stat-rd-performance-rankings-pharma 2026-05-23T21:53:26.674Z daily 0.7 https://novapharmanews.com/us/articles/merck-adc-global-trial-results 2026-05-23T21:40:46.270Z daily 0.7 https://novapharmanews.com/us/articles/amgen-tavneos-japan-liver-toxicity-report 2026-05-23T20:24:28.636Z daily 0.7 https://novapharmanews.com/us/articles/fda-unreleased-covid-vaccine-deaths-report 2026-05-23T16:27:13.660Z daily 0.7 https://novapharmanews.com/us/articles/palvella-nasdaq-uplisting-rare-disease 2026-05-23T13:54:26.109Z daily 0.7 https://novapharmanews.com/us/articles/merck-adc-global-trial-success 2026-05-23T09:56:41.824Z daily 0.7 https://novapharmanews.com/us/articles/britain-tobacco-regulation-massachusetts-experiment 2026-05-23T05:05:38.003Z daily 0.7 https://novapharmanews.com/us/articles/stat-rd-performance-ranking-pharma 2026-05-23T21:44:09.993Z daily 0.7 https://novapharmanews.com/us/articles/supreme-court-setback-pharma-trumprx-expansion 2026-05-23T21:02:34.645Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-pharma-rd-rankings 2026-05-23T19:15:59.706Z daily 0.7 https://novapharmanews.com/us/articles/wave-monthly-dosing-aatd-treatment 2026-05-23T19:10:25.310Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-pharma-rd-performance 2026-05-23T18:14:27.032Z daily 0.7 https://novapharmanews.com/us/articles/supreme-court-pharma-pricing-deals 2026-05-23T18:10:25.565Z daily 0.7 https://novapharmanews.com/us/articles/migraine-drugmaker-public-market-reverse-merger 2026-05-23T17:06:37.057Z daily 0.7 https://novapharmanews.com/us/articles/spine-surgery-no-surprises-act-arbitration 2026-05-23T18:29:46.814Z daily 0.7 https://novapharmanews.com/us/articles/canadian-medical-societies-conflict-of-interest 2026-05-23T16:59:29.552Z daily 0.7 https://novapharmanews.com/eu/articles/global-pharma-tech-2026 2026-05-23T06:44:43.752Z daily 0.7 https://novapharmanews.com/us/articles/wave-monthly-dosing-rna-editing-aatd 2026-05-23T05:06:04.027Z daily 0.7 https://novapharmanews.com/eu/articles/ema-critical-medicines-act-2023 2026-05-23T21:01:29.890Z daily 0.7 https://novapharmanews.com/us/articles/novartis-terminates-porton-contract 2026-05-23T11:33:01.094Z daily 0.7 https://novapharmanews.com/us/articles/impact-600-new-generic-meds-pharma-landscape 2026-05-23T11:15:12.652Z daily 0.7 https://novapharmanews.com/us/articles/no-surprises-act-spine-surgery-costs 2026-05-23T05:25:09.177Z daily 0.7 https://novapharmanews.com/eu/articles/global-pharma-tech-2026-event-coverage 2026-05-23T23:17:49.148Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-caitlin-clark-sports-courts-indianapolis 2026-05-23T20:34:59.366Z daily 0.7 https://novapharmanews.com/us/articles/trump-cms-skimpier-plans-aca-exchanges 2026-05-23T14:57:46.801Z daily 0.7 https://novapharmanews.com/us/articles/supreme-court-drugmakers-ira-cases 2026-05-23T12:00:31.223Z daily 0.7 https://novapharmanews.com/us/articles/merck-adc-sac-tmt-phase-3-success 2026-05-23T09:18:11.926Z daily 0.7 https://novapharmanews.com/us/articles/waked-med-atrium-health-merger-significance 2026-05-23T05:06:22.015Z daily 0.7 https://novapharmanews.com/us/articles/medical-affairs-impact-launch 2026-05-23T05:06:18.034Z daily 0.7 https://novapharmanews.com/us/articles/regeneron-phase-3-skin-cancer-lag-3-failures 2026-05-23T22:16:31.806Z daily 0.7 https://novapharmanews.com/us/articles/fda-shakeup-hoeg-amgen-drug-concerns 2026-05-23T20:54:41.533Z daily 0.7 https://novapharmanews.com/us/articles/ebola-outbreak-experts-consider-unapproved-vaccine-testing 2026-05-23T19:30:41.233Z daily 0.7 https://novapharmanews.com/eu/articles/driving-impact-at-launch-medical-affairs 2026-05-23T19:05:54.244Z daily 0.7 https://novapharmanews.com/us/articles/biomarin-rare-disease-therapy-phase-3-results 2026-05-23T15:45:47.264Z daily 0.7 https://novapharmanews.com/eu/articles/eli-lilly-caitlin-clark-sports-courts-indianapolis 2026-05-23T12:10:42.651Z daily 0.7 https://novapharmanews.com/us/articles/white-house-amazon-goodrx-mark-cuban-trumprx 2026-05-23T12:05:11.558Z daily 0.7 https://novapharmanews.com/us/articles/navigating-ghost-approval-heart-transplant-medication 2026-05-23T10:14:34.655Z daily 0.7 https://novapharmanews.com/us/articles/latest-on-ebola-travel-ban-old-vaccine 2026-05-23T09:00:23.912Z daily 0.7 https://novapharmanews.com/us/articles/impact-alcohol-consumption-pregnancy-pharma 2026-05-23T07:40:20.563Z daily 0.7 https://novapharmanews.com/us/articles/white-house-amazon-goodrx-trumprx 2026-05-23T07:00:41.446Z daily 0.7 https://novapharmanews.com/us/articles/amgen-tavneos-liver-toxicity-japan 2026-05-23T05:42:04.118Z daily 0.7 https://novapharmanews.com/eu/articles/europabio-biomanufacturing-policy-summit-2026 2026-05-23T05:09:55.128Z daily 0.7 https://novapharmanews.com/us/articles/maryland-caps-ozempic-price 2026-05-23T05:06:48.054Z daily 0.7 https://novapharmanews.com/us/articles/ghost-approval-heart-transplant-medications 2026-05-23T05:06:36.046Z daily 0.7 https://novapharmanews.com/us/articles/full-life-technologies-quince-pulmonary-drug 2026-05-23T17:31:05.956Z daily 0.7 https://novapharmanews.com/us/articles/alcohol-consumption-pregnancy-impact 2026-05-23T15:12:14.548Z daily 0.7 https://novapharmanews.com/us/articles/ghost-approval-heart-transplant-medication 2026-05-23T12:06:56.727Z daily 0.7 https://novapharmanews.com/us/articles/relay-drug-promise-rare-blood-vessel-diseases 2026-05-23T12:00:58.598Z daily 0.7 https://novapharmanews.com/us/articles/nourish-raises-100m-virtual-nutrition-care 2026-05-23T06:34:09.581Z daily 0.7 https://novapharmanews.com/us/articles/nourish-secures-100m-virtual-nutrition-care 2026-05-23T05:54:17.982Z daily 0.7 https://novapharmanews.com/us/articles/roche-alecensa-japan-expansion-alk-tumors 2026-05-23T05:45:56.186Z daily 0.7 https://novapharmanews.com/apac/articles/kelun-biotech-sk118-cde-approval 2026-05-23T05:23:18.283Z daily 0.7 https://novapharmanews.com/us/articles/fda-approves-astrazeneca-baxdrostat-hypertension 2026-05-23T19:46:23.928Z daily 0.7 https://novapharmanews.com/us/articles/texas-opens-detransition-clinic 2026-05-23T05:07:20.070Z daily 0.7 https://novapharmanews.com/us/articles/china-question-tearing-biotech-apart 2026-05-23T05:07:18.088Z daily 0.7 https://novapharmanews.com/us/articles/supreme-court-medicare-drug-price-negotiation 2026-05-23T23:01:12.615Z daily 0.7 https://novapharmanews.com/us/articles/us-biotech-china-problem-regeneron-flop 2026-05-23T22:25:17.656Z daily 0.7 https://novapharmanews.com/us/articles/design-therapeutics-vincentage-data-insights 2026-05-23T21:33:12.388Z daily 0.7 https://novapharmanews.com/eu/articles/future-ai-pharma-marketing-cmi-media-group 2026-05-23T20:45:55.356Z daily 0.7 https://novapharmanews.com/us/articles/regeneron-parabilis-deal-drug-targets 2026-05-23T17:28:08.356Z daily 0.7 https://novapharmanews.com/us/articles/from-reach-to-relevance-pharma-marketing 2026-05-23T05:07:30.090Z daily 0.7 https://novapharmanews.com/eu/articles/medical-affairs-impact-launch 2026-05-23T05:07:26.091Z daily 0.7 https://novapharmanews.com/us/articles/regeneron-phase-3-skin-cancer-miss-lag-3 2026-05-23T22:43:21.523Z daily 0.7 https://novapharmanews.com/us/articles/trump-cms-aca-exchanges-catastrophic-coverage 2026-05-23T22:29:17.253Z daily 0.7 https://novapharmanews.com/us/articles/astrazeneca-fda-approval-hypertension-drug 2026-05-23T17:10:31.610Z daily 0.7 https://novapharmanews.com/us/articles/amgen-tavneos-japan-liver-toxicity 2026-05-23T16:20:32.104Z daily 0.7 https://novapharmanews.com/us/articles/friedreichs-ataxia-obesity-results 2026-05-23T07:45:26.410Z daily 0.7 https://novapharmanews.com/us/articles/wakemed-atrium-health-merger-implications 2026-05-23T05:07:46.073Z daily 0.7 https://novapharmanews.com/us/articles/us-bans-entry-ebola-affected-countries 2026-05-23T05:07:40.100Z daily 0.7 https://novapharmanews.com/eu/articles/eli-lilly-caitlin-clark-indianapolis-sports-courts 2026-05-23T20:13:37.653Z daily 0.7 https://novapharmanews.com/eu/articles/daiichi-astrazeneca-enhertu-early-breast-cancer-approval 2026-05-23T14:52:15.590Z daily 0.7 https://novapharmanews.com/apac/articles/eli-lilly-caitlin-clark-sports-courts-indianapolis 2026-05-23T08:49:31.306Z daily 0.7 https://novapharmanews.com/us/articles/ebola-outbreak-testing-long-shot-vaccines 2026-05-23T06:52:12.467Z daily 0.7 https://novapharmanews.com/eu/articles/nice-approves-imfinzi-stomach-cancer-regulatory-update 2026-05-23T16:14:34.793Z daily 0.7 https://novapharmanews.com/us/articles/waked-med-atrium-health-merger-matters 2026-05-23T10:01:24.375Z daily 0.7 https://novapharmanews.com/eu/articles/daiichi-astrazeneca-enhertu-fda-approvals-analysis 2026-05-23T05:40:12.588Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-caitlin-clark-community-engagement 2026-05-23T05:08:04.088Z daily 0.7 https://novapharmanews.com/eu/articles/novartis-terminates-porton-contract 2026-05-23T05:07:58.099Z daily 0.7 https://novapharmanews.com/us/articles/design-therapeutics-friedreichs-ataxia-vincentage-obesity-results 2026-05-23T22:41:31.477Z daily 0.7 https://novapharmanews.com/eu/articles/global-pharma-tech-2026-coverage 2026-05-23T21:37:45.139Z daily 0.7 https://novapharmanews.com/us/articles/enhertu-dual-fda-approvals-early-breast-cancer 2026-05-23T18:24:10.305Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-sports-initiatives-indianapolis 2026-05-23T05:08:18.115Z daily 0.7 https://novapharmanews.com/us/articles/stat-wakemed-atrium-health-merger 2026-05-23T05:08:16.186Z daily 0.7 https://novapharmanews.com/us/articles/future-ai-pharma-marketing 2026-05-23T05:08:12.101Z daily 0.7 https://novapharmanews.com/us/articles/wegovy-pill-scripts-decline-pharma-implications 2026-05-23T21:01:40.361Z daily 0.7 https://novapharmanews.com/apac/articles/doceree-daily-command-ai-platform 2026-05-23T09:15:38.724Z daily 0.7 https://novapharmanews.com/us/articles/nice-approves-imfinzi-stomach-cancer 2026-05-23T06:09:19.749Z daily 0.7 https://novapharmanews.com/us/articles/eisai-leqembi-sales-forecast 2026-05-23T05:08:34.111Z daily 0.7 https://novapharmanews.com/apac/articles/scotus-telehealth-access-mifepristone 2026-05-23T05:08:32.132Z daily 0.7 https://novapharmanews.com/us/articles/understanding-fda-response-marty-makary 2026-05-23T05:08:28.101Z daily 0.7 https://novapharmanews.com/us/articles/roche-ctdna-approach-bladder-cancer-tecentriq 2026-05-23T05:08:26.106Z daily 0.7 https://novapharmanews.com/us/articles/cloudy-truth-blue-zones 2026-05-23T05:08:24.129Z daily 0.7 https://novapharmanews.com/us/articles/cder-leadership-changes-fda 2026-05-23T05:08:22.132Z daily 0.7 https://novapharmanews.com/us/articles/navigating-new-policy-landscape-pharma 2026-05-23T05:08:20.120Z daily 0.7 https://novapharmanews.com/us/articles/doceree-daily-command-ai-platform 2026-05-23T16:26:08.477Z daily 0.7 https://novapharmanews.com/eu/articles/eisai-leqembi-sales-forecast 2026-05-23T05:08:42.110Z daily 0.7 https://novapharmanews.com/us/articles/doceree-launches-daily-command-ai-platform 2026-05-23T05:08:40.133Z daily 0.7 https://novapharmanews.com/eu/articles/doceree-launches-daily-command-ai-platform 2026-05-23T18:14:23.580Z daily 0.7 https://novapharmanews.com/us/articles/manufacturing-challenges-biopharma 2026-05-23T16:28:38.752Z daily 0.7 https://novapharmanews.com/us/articles/navigating-manufacturing-challenges-biologics 2026-05-23T06:24:19.764Z daily 0.7 https://novapharmanews.com/us/articles/trump-challenge-sen-cassidy-louisiana-primary 2026-05-23T05:43:44.553Z daily 0.7 https://novapharmanews.com/us/articles/cder-leadership-changes-pharma-strategy 2026-05-23T22:17:26.171Z daily 0.7 https://novapharmanews.com/apac/articles/doceree-launches-daily-command-ai-platform 2026-05-23T17:21:39.188Z daily 0.7 https://novapharmanews.com/us/articles/pfizer-latest-developments-insights 2026-05-23T13:16:57.161Z daily 0.7 https://novapharmanews.com/us/articles/uk-advocacy-groups-challenge-pharma-trade-deal 2026-05-23T08:47:53.207Z daily 0.7 https://novapharmanews.com/us/articles/sen-bill-cassidy-loses-primary-pharma-implications 2026-05-23T06:21:21.339Z daily 0.7 https://novapharmanews.com/us/articles/when-should-you-get-a-mammogram-conflicting-advice 2026-05-23T05:09:08.698Z daily 0.7 https://novapharmanews.com/apac/articles/eisai-leqembi-sales-forecast-game-changer 2026-05-23T05:09:01.773Z daily 0.7 https://novapharmanews.com/us/articles/hantavirus-outbreak-lessons-from-covid-19 2026-05-23T05:08:58.136Z daily 0.7 https://novapharmanews.com/us/articles/ebola-outbreak-american-exposure-congo 2026-05-23T05:08:54.141Z daily 0.7 https://novapharmanews.com/eu/articles/nice-endorses-imfinzi-stomach-cancer-regulatory-insights 2026-05-23T22:16:37.008Z daily 0.7 https://novapharmanews.com/us/articles/leadership-changes-cder-cber-oncology 2026-05-23T21:01:35.032Z daily 0.7 https://novapharmanews.com/us/articles/fda-shakeup-oncology-covid-antidepressants 2026-05-23T08:42:35.235Z daily 0.7 https://novapharmanews.com/apac/articles/kelun-biotech-new-drug-approval-skb118 2026-05-23T07:50:54.848Z daily 0.7 https://novapharmanews.com/us/articles/palvella-pivotal-data-cash-runway-rare-diseases 2026-05-23T05:34:04.249Z daily 0.7 https://novapharmanews.com/us/articles/mammogram-guidelines-pharma-insights 2026-05-23T05:09:24.131Z daily 0.7 https://novapharmanews.com/us/articles/ebola-exposure-risk-pharma-stakeholders 2026-05-23T05:09:22.139Z daily 0.7 https://novapharmanews.com/apac/articles/bms-hengrui-15b-deal-analysis 2026-05-23T20:00:00.156Z daily 0.7 https://novapharmanews.com/eu/articles/eisai-leqembi-sales-forecast-blockbuster 2026-05-23T17:28:30.693Z daily 0.7 https://novapharmanews.com/us/articles/biologics-manufacturing-challenges-biopharma 2026-05-23T07:16:58.836Z daily 0.7 https://novapharmanews.com/us/articles/patient-autonomy-childhood-vaccines 2026-05-23T05:09:40.175Z daily 0.7 https://novapharmanews.com/us/articles/leadership-changes-fda-implications-pharma 2026-05-23T05:09:38.157Z daily 0.7 https://novapharmanews.com/us/articles/unlocking-value-mature-drug-products-outsourcing 2026-05-23T05:09:36.156Z daily 0.7 https://novapharmanews.com/apac/articles/roches-ctdna-guided-approach-bladder-cancer 2026-05-23T05:09:34.181Z daily 0.7 https://novapharmanews.com/us/articles/restore-credibility-cdc-vaccine-advisory-committee 2026-05-23T05:09:32.159Z daily 0.7 https://novapharmanews.com/us/articles/navigating-manufacturing-challenges-biopharma 2026-05-23T05:09:30.143Z daily 0.7 https://novapharmanews.com/us/articles/ebola-exposure-congo-pharma-implications 2026-05-23T05:09:28.157Z daily 0.7 https://novapharmanews.com/eu/articles/case-for-direct-to-patient-execution-challenges 2026-05-23T21:02:07.952Z daily 0.7 https://novapharmanews.com/eu/articles/reframing-pharma-commercialization 2026-05-23T20:13:57.880Z daily 0.7 https://novapharmanews.com/us/articles/pharma-brands-consumer-branding 2026-05-23T05:10:04.188Z daily 0.7 https://novapharmanews.com/us/articles/manufacturing-challenges-biopharma-biologics 2026-05-23T05:10:00.187Z daily 0.7 https://novapharmanews.com/eu/articles/why-pharma-isnt-first-voice-in-the-room 2026-05-23T05:09:58.242Z daily 0.7 https://novapharmanews.com/us/articles/ai-search-pharma-marketing 2026-05-23T05:09:56.177Z daily 0.7 https://novapharmanews.com/us/articles/china-question-biotech-divide 2026-05-23T05:09:54.173Z daily 0.7 https://novapharmanews.com/us/articles/regeneron-immunotherapy-combo-fails-melanoma-trial 2026-05-23T05:09:52.172Z daily 0.7 https://novapharmanews.com/us/articles/ai-patient-centric-pharma-marketing 2026-05-23T05:09:50.254Z daily 0.7 https://novapharmanews.com/us/articles/compliance-data-pharma-tv-marketing 2026-05-23T05:09:48.642Z daily 0.7 https://novapharmanews.com/us/articles/navigating-direct-to-patient-strategies-pharma 2026-05-23T05:09:46.182Z daily 0.7 https://novapharmanews.com/us/articles/executive-interviews-fierce-pharma-engage-2026 2026-05-23T20:10:15.991Z daily 0.7 https://novapharmanews.com/eu/articles/reach-to-relevance-pharma-marketing 2026-05-23T20:06:43.417Z daily 0.7 https://novapharmanews.com/us/articles/daiichi-astrazeneca-enhertu-early-breast-cancer-approval 2026-05-23T07:11:51.152Z daily 0.7 https://novapharmanews.com/us/articles/precision-engagement-pharma-pharmaforceiq 2026-05-23T05:10:12.178Z daily 0.7 https://novapharmanews.com/us/articles/fda-approves-astrazeneca-hypertension-drug 2026-05-23T05:45:36.478Z daily 0.7 https://novapharmanews.com/eu/articles/contact-us-for-membership 2026-05-23T05:21:56.168Z daily 0.7 https://novapharmanews.com/us/articles/us-travel-ban-ebola-affected-countries 2026-05-23T05:10:18.173Z daily 0.7 https://novapharmanews.com/us/articles/biogen-alzheimers-data-leadership-changes 2026-05-23T05:10:22.214Z daily 0.7 https://novapharmanews.com/us/articles/latest-comings-and-goings-pharma-leadership 2026-05-23T09:18:51.473Z daily 0.7 https://novapharmanews.com/us/articles/global-preparedness-hantavirus-ebola-outbreaks 2026-05-23T05:10:34.178Z daily 0.7 https://novapharmanews.com/us/articles/marty-makary-fda-misunderstanding 2026-05-23T05:10:32.221Z daily 0.7 https://novapharmanews.com/apac/articles/navigating-manufacturing-hurdles-biopharma 2026-05-23T05:10:30.201Z daily 0.7 https://novapharmanews.com/us/articles/biopharma-ma-trends-resilience-amidst-large-deal-decline 2026-05-23T05:10:28.208Z daily 0.7 https://novapharmanews.com/us/articles/takeda-settles-kickback-allegations 2026-05-23T05:10:24.196Z daily 0.7 https://novapharmanews.com/us/articles/new-ebola-outbreak-congo-2026 2026-05-23T16:11:22.890Z daily 0.7 https://novapharmanews.com/us/articles/uk-political-contest-drug-pricing 2026-05-23T05:10:58.228Z daily 0.7 https://novapharmanews.com/us/articles/asgct26-zillow-like-marketplace-abandoned-gene-therapies 2026-05-23T05:10:56.230Z daily 0.7 https://novapharmanews.com/us/articles/fda-hold-aardvark-prader-willi-drug-limbo 2026-05-23T05:10:54.208Z daily 0.7 https://novapharmanews.com/us/articles/leadership-changes-ac-immune-acadia 2026-05-23T05:10:52.216Z daily 0.7 https://novapharmanews.com/us/articles/makarys-out-at-fda-future-implications 2026-05-23T05:10:50.266Z daily 0.7 https://novapharmanews.com/us/articles/amgen-crackdown-340b-program-misuse 2026-05-23T05:10:48.184Z daily 0.7 https://novapharmanews.com/us/articles/ma-mid-size-pharma-deal-hunts 2026-05-23T05:10:46.215Z daily 0.7 https://novapharmanews.com/us/articles/cder-leadership-changes-implications-pharma 2026-05-23T05:10:44.220Z daily 0.7 https://novapharmanews.com/us/articles/aardvark-next-move-clinical-hold-alumis-acelyrin 2026-05-23T05:10:42.208Z daily 0.7 https://novapharmanews.com/us/articles/supreme-court-abortion-pill-mail 2026-05-23T05:10:38.211Z daily 0.7 https://novapharmanews.com/us/articles/us-pressure-germany-drug-prices-fda-upheaval 2026-05-23T05:10:36.199Z daily 0.7 https://novapharmanews.com/us/articles/makary-resigns-biogen-alzheimers-data 2026-05-23T23:08:32.507Z daily 0.7 https://novapharmanews.com/us/articles/candel-prostate-cancer-drug-long-term-data-fda-filing 2026-05-23T07:53:43.603Z daily 0.7 https://novapharmanews.com/us/articles/trump-disloyalty-sen-cassidy-louisiana-primary 2026-05-23T05:11:06.226Z daily 0.7 https://novapharmanews.com/us/articles/supreme-court-mifepristone-mail-access 2026-05-23T05:11:04.215Z daily 0.7 https://novapharmanews.com/us/articles/stat-up-and-down-the-ladder-latest-comings-and-goings 2026-05-23T05:11:02.196Z daily 0.7 https://novapharmanews.com/us/articles/us-pressure-germany-drug-prices 2026-05-23T18:24:15.938Z daily 0.7 https://novapharmanews.com/us/articles/eisai-leqembi-sales-forecast-900m 2026-05-23T09:07:33.098Z daily 0.7 https://novapharmanews.com/apac/articles/manufacturing-challenges-biopharma 2026-05-23T07:37:09.631Z daily 0.7 https://novapharmanews.com/us/articles/fda-leadership-vacuum-tracy-beth-hoeg 2026-05-23T05:11:28.240Z daily 0.7 https://novapharmanews.com/us/articles/bms-hengrui-15b-deal-analysis 2026-05-23T05:11:26.252Z daily 0.7 https://novapharmanews.com/eu/articles/oral-glp-1-tracker-wegovy-scripts-decline 2026-05-23T05:11:24.213Z daily 0.7 https://novapharmanews.com/us/articles/trump-blasts-sen-cassidy-louisiana-primary 2026-05-23T05:11:18.234Z daily 0.7 https://novapharmanews.com/us/articles/biopharma-ma-strength-declining-large-deals 2026-05-23T05:11:16.236Z daily 0.7 https://novapharmanews.com/apac/articles/scotus-restores-telehealth-access-mifepristone 2026-05-23T05:11:12.224Z daily 0.7 https://novapharmanews.com/us/articles/ispor-2026-international-event-coverage 2026-05-23T05:11:10.242Z daily 0.7 https://novapharmanews.com/us/articles/nice-approval-imfinzi-stomach-cancer 2026-05-23T23:18:09.476Z daily 0.7 https://novapharmanews.com/eu/articles/roche-elevidys-study-launch-eu-rejection 2026-05-23T20:47:16.139Z daily 0.7 https://novapharmanews.com/us/articles/takeda-settlement-kickbacks-doctors 2026-05-23T17:21:06.403Z daily 0.7 https://novapharmanews.com/us/articles/amgen-340b-program-crackdown 2026-05-23T13:05:36.903Z daily 0.7 https://novapharmanews.com/us/articles/biotech-leaders-push-for-pazdur-takeda-layoffs 2026-05-23T12:27:03.875Z daily 0.7 https://novapharmanews.com/us/articles/political-contest-uk-drug-pricing 2026-05-23T07:59:44.418Z daily 0.7 https://novapharmanews.com/us/articles/indias-pharma-industry-global-compete-china 2026-05-23T07:47:29.591Z daily 0.7 https://novapharmanews.com/apac/articles/rusan-pharma-gmp-clearance-pmda 2026-05-23T05:42:42.239Z daily 0.7 https://novapharmanews.com/eu/articles/navigating-manufacturing-challenges-biopharma 2026-05-23T05:11:52.270Z daily 0.7 https://novapharmanews.com/us/articles/us-cancer-clinics-revolution-medicines-pancreatic-cancer-drug 2026-05-23T05:11:50.258Z daily 0.7 https://novapharmanews.com/us/articles/cder-chief-hoeg-fired-fda-implications-pharma 2026-05-23T05:11:46.263Z daily 0.7 https://novapharmanews.com/us/articles/holland-knight-health-dose-oncology-may-12-2026 2026-05-23T05:11:42.254Z daily 0.7 https://novapharmanews.com/us/articles/understanding-fda-marty-makary-opinion 2026-05-23T20:33:12.458Z daily 0.7 https://novapharmanews.com/us/articles/nice-backs-imfinzi-stomach-cancer 2026-05-23T06:46:50.555Z daily 0.7 https://novapharmanews.com/eu/articles/eisai-leqembi-sales-forecast-blockbuster-status 2026-05-23T13:53:13.627Z daily 0.7 https://novapharmanews.com/eu/articles/tracy-beth-hoeg-departure-fda 2026-05-23T12:22:05.968Z daily 0.7 https://novapharmanews.com/us/articles/roche-ctdna-bladder-cancer-tecentriq 2026-05-23T11:02:19.365Z daily 0.7 https://novapharmanews.com/apac/articles/cder-leadership-changes-impact-pharma 2026-05-23T05:12:04.266Z daily 0.7 https://novapharmanews.com/us/articles/fda-leadership-changes-tracy-beth-hoeg-resignation 2026-05-23T05:12:00.275Z daily 0.7 https://novapharmanews.com/us/articles/cloudy-truth-about-blue-zones 2026-05-23T12:01:41.340Z daily 0.7 https://novapharmanews.com/us/articles/trump-criticizes-cassidy-louisiana-primary 2026-05-23T05:12:10.248Z daily 0.7 https://novapharmanews.com/us/articles/who-ebola-outbreak-international-emergency 2026-05-23T05:12:08.275Z daily 0.7 https://novapharmanews.com/eu/articles/veeva-rd-event-preview-2026 2026-05-23T05:12:14.248Z daily 0.7 https://novapharmanews.com/us/articles/asco-2026-oncology-drug-pipeline-preview 2026-05-23T05:12:16.247Z daily 0.7 https://novapharmanews.com/us/articles/fda-eli-lilly-zepbound-obstructive-sleep-apnea-approval 2026-05-23T05:12:18.254Z daily 0.7 https://novapharmanews.com/us/articles/bio-2026-preview-companies-to-watch-key-catalysts 2026-05-23T05:12:20.274Z daily 0.7 https://novapharmanews.com/eu/articles/purdue-pharma-shutdown-opioid-settlement 2026-05-23T05:12:22.273Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-pfizer-arvinas-breast-cancer-drug-vepdegestrant 2026-05-23T11:00:13.913Z daily 0.7 https://novapharmanews.com/apac/articles/reckitt-benckiser-layoffs-new-jersey-mucinex 2026-05-23T05:12:26.294Z daily 0.7 https://novapharmanews.com/apac/articles/reckitt-benckiser-layoffs-mucinex-nj 2026-05-23T05:12:28.297Z daily 0.7 https://novapharmanews.com/apac/articles/auvelity-fda-approval-mdd-treatment 2026-05-23T05:12:30.287Z daily 0.7 https://novapharmanews.com/eu/articles/orchard-therapeutics-otl-201-innovation-passport-mps-iiia 2026-05-23T05:12:32.260Z daily 0.7 https://novapharmanews.com/us/articles/auvelity-fda-approval-mdd-treatment 2026-05-23T05:12:34.287Z daily 0.7 https://novapharmanews.com/us/articles/fda-scrutiny-post-market-data-pharma-investment-2024 2026-05-23T08:52:04.013Z daily 0.7 https://novapharmanews.com/us/articles/fda-inflation-reduction-act-pharmaceutical-pricing-2026 2026-05-23T12:58:56.743Z daily 0.7 https://novapharmanews.com/eu/articles/nice-technology-appraisals-oncology-market-access-2024 2026-05-23T05:12:40.292Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-sakigake-accelerated-approval-bispecific-antibodies-leukemia-2026 2026-05-23T21:47:45.464Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-clinical-trial-changes-brazil-2024 2026-05-23T05:12:44.275Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-regulatory-changes-foreign-drug-manufacturers-market-access-2024 2026-05-23T05:37:22.839Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-accelerated-approval-oncology-2024 2026-05-23T05:12:48.286Z daily 0.7 https://novapharmanews.com/us/articles/ama-harmonizing-clinical-trials-impact-2024 2026-05-23T13:19:03.733Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-policy-local-pharmaceutical-manufacturing-south-africa-2025 2026-05-23T11:45:26.230Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-oncology-market-pricing-2026 2026-05-23T12:03:29.106Z daily 0.7 https://novapharmanews.com/us/articles/fda-guidance-accelerated-approval-oncology-2025 2026-05-23T23:13:34.643Z daily 0.7 https://novapharmanews.com/eu/articles/mhra-post-brexit-drug-approval-market-analysis-2026 2026-05-23T05:12:58.276Z daily 0.7 https://novapharmanews.com/eu/articles/ema-market-analysis-car-t-cell-therapy-europe-2024 2026-05-23T19:19:31.226Z daily 0.7 https://novapharmanews.com/eu/articles/ema-market-analysis-biosimilar-uptake-eu-2024 2026-05-23T23:20:41.318Z daily 0.7 https://novapharmanews.com/apac/articles/cdsco-pmda-tga-harmonization-clinical-trial-regulations-2026 2026-05-23T05:13:05.294Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-approval-cannabis-framework-magictouch-2026 2026-05-23T05:13:06.314Z daily 0.7 https://novapharmanews.com/us/articles/cofepris-approval-trends-new-drug-approvals-2026 2026-05-23T05:13:08.317Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-new-clinical-trial-regulations-foreign-pharma-2025 2026-05-23T07:11:12.797Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-cofepris-dct-growth-latam-2024 2026-05-23T05:13:12.326Z daily 0.7 https://novapharmanews.com/us/articles/cofepris-approval-novel-immunotherapies-advanced-melanoma-2024 2026-05-23T05:13:14.324Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-regulatory-changes-biosimilars-growth-brazil-2024 2026-05-23T06:30:20.016Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-regulatory-changes-oncology-fast-track-approvals-2025 2026-05-23T05:13:18.349Z daily 0.7 https://novapharmanews.com/us/articles/ama-approval-cabotegravir-rilpivirine-hiv-treatment-2024 2026-05-23T18:51:17.560Z daily 0.7 https://novapharmanews.com/us/articles/moh-uae-cancer-immunotherapies-adoption-2025 2026-05-23T05:13:22.308Z daily 0.7 https://novapharmanews.com/apac/articles/purdue-pharma-shutdown-oxycontin-settlement 2026-05-23T07:09:26.660Z daily 0.7 https://novapharmanews.com/eu/articles/auvelity-fda-approval-mdd-treatment 2026-05-23T06:37:14.875Z daily 0.7 https://novapharmanews.com/us/articles/plozasiran-tga-approval-australia-redemplo- FCS 2026-05-23T05:13:28.774Z daily 0.7 https://novapharmanews.com/us/articles/mounjaro-fda-approval-tirzepatide-eli-lilly 2026-05-23T05:13:30.322Z daily 0.7 https://novapharmanews.com/us/articles/mounjaro-fda-approval-obesity-tirzepatide-eli-lilly 2026-05-23T05:13:32.408Z daily 0.7 https://novapharmanews.com/us/articles/osimertinib-fda-approval-early-stage-nsclc 2026-05-23T17:44:48.246Z daily 0.7 https://novapharmanews.com/us/articles/ama-regulatory-harmonization-pharmaceutical-market-access-2026 2026-05-23T07:09:16.283Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-accelerated-approval-pathway-innovative-drug-market-entry-2024 2026-05-23T05:13:38.311Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-approval-pd1-pdl1-lung-cancer-immunotherapy-2025 2026-05-23T14:16:03.385Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-conditional-approval-pathway-oncology-access-2024 2026-05-23T13:29:45.695Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-pharmaceutical-legislation-reform-orphan-drug-market-exclusivity-2026 2026-05-23T16:27:18.011Z daily 0.7 https://novapharmanews.com/eu/articles/ema-market-analysis-antibody-drug-conjugates-breast-cancer-2025 2026-05-23T05:13:46.342Z daily 0.7 https://novapharmanews.com/eu/articles/ema-conditional-marketing-authorization-linvoseltamab-rrmm-2025 2026-05-23T05:13:48.437Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-clinical-trials-regulation-impact-rare-disease-2024 2026-05-23T05:13:50.360Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-analysis-bispecific-antibodies-hematological-malignancies-2024 2026-05-23T08:44:10.574Z daily 0.7 https://novapharmanews.com/us/articles/fda-analysis-semaglutide-posdinemab-alzheimers-failures-2025 2026-05-23T23:29:53.423Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-oncoblast-market-impact-advanced-melanoma 2026-05-23T09:16:00.929Z daily 0.7 https://novapharmanews.com/apac/articles/ama-implementation-regulatory-harmonization-pharmaceutical-market-access-2026 2026-05-23T05:13:58.341Z daily 0.7 https://novapharmanews.com/apac/articles/nmepa-priority-review-pathway-innovative-drug-approvals-2024 2026-05-23T05:14:00.331Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-pharmaceutical-legislation-reform-generic-biosimilar-market-2026 2026-05-23T21:40:54.489Z daily 0.7 https://novapharmanews.com/eu/articles/ema-approval-teclistamab-elranatamab-multiple-myeloma-2024 2026-05-23T05:14:04.373Z daily 0.7 https://novapharmanews.com/eu/articles/ema-conditional-approval-car-t-relapsed-b-cell-lymphomas-2024 2026-05-23T23:17:44.579Z daily 0.7 https://novapharmanews.com/eu/articles/ema-conditional-approval-repotrectinib-oncology-patient-access-2026 2026-05-23T05:14:08.365Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-zongertinib-oncology-2026 2026-05-23T05:14:10.329Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-analysis-kras-g12c-inhibitors-nsclc-2024 2026-05-23T22:30:52.263Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-elranatamab-rrmm-2023 2026-05-23T15:21:43.804Z daily 0.7 https://novapharmanews.com/us/articles/fda-analysis-car-t-therapy-clinical-trials-asco-2026 2026-05-23T05:14:16.359Z daily 0.7 https://novapharmanews.com/us/articles/fda-guidance-decentralized-clinical-trials-2024 2026-05-23T23:11:12.185Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-elarekig-treatment-resistant-depression-2026 2026-05-23T14:59:49.388Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-reforms-china-clinical-trial-regulations-2024 2026-05-23T23:31:38.352Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-oncology-evolving-pathways-2026 2026-05-23T23:16:23.667Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-reforms-oncology-market-access-2026 2026-05-23T23:13:41.456Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-pathway-oncology-market-access-2026 2026-05-23T23:13:35.542Z daily 0.7 https://novapharmanews.com/us/articles/sfda-expedited-drug-approval-saudi-pharmaceutical-market-2024 2026-05-23T22:20:15.155Z daily 0.7 https://novapharmanews.com/us/articles/fda-companion-diagnostic-policies-precision-oncology-2025 2026-05-23T22:19:22.480Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-oncology-benefit-risk-2026 2026-05-23T22:05:48.547Z daily 0.7 https://novapharmanews.com/eu/articles/ema-biosimilar-oncology-antibodies-market-impact-2024 2026-05-23T21:41:56.119Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-regulatory-update-biosimilars-market-analysis-2024 2026-05-23T20:02:36.300Z daily 0.7 https://novapharmanews.com/apac/articles/nmepa-data-integrity-foreign-pharma-compliance-2026 2026-05-23T17:24:55.321Z daily 0.7 https://novapharmanews.com/apac/articles/nmepa-data-integrity-requirements-foreign-pharma-apac-2024 2026-05-23T16:46:10.609Z daily 0.7 https://novapharmanews.com/us/articles/fda-inflation-reduction-act-drug-pricing-negotiations-2026 2026-05-23T16:37:57.430Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-acceptance-foreign-clinical-trial-data-impact-2024 2026-05-23T15:29:02.963Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-biosimilar-regulation-japan-2024-analysis 2026-05-23T14:39:11.746Z daily 0.7 https://novapharmanews.com/us/articles/fda-phase2-failure-posdinemab-alzheimers-market-analysis-2025 2026-05-23T10:54:45.033Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-regulatory-update-biosimilar-landscape-japan-2024 2026-05-23T10:05:59.394Z daily 0.7 https://novapharmanews.com/us/articles/fda-validation-framework-ai-oncology-drug-development-2025 2026-05-23T08:34:16.666Z daily 0.7 https://novapharmanews.com/apac/articles/nmra-clinical-trial-quality-management-apac-2024 2026-05-23T07:11:54.396Z daily 0.7 https://novapharmanews.com/us/articles/fda-biosimilars-approval-market-analysis-2026 2026-05-23T06:57:42.467Z daily 0.7 https://novapharmanews.com/eu/articles/ema-hta-regulation-impact-rare-disease-drug-approval-2026 2026-05-23T06:34:05.376Z daily 0.7 https://novapharmanews.com/apac/articles/nmepa-data-integrity-foreign-pharma-approval-2024 2026-05-23T05:15:36.409Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-elarekibart-treatment-resistant-hypertension-2026 2026-05-23T05:15:34.422Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-approval-biosimilar-market-growth-japan-2024 2026-05-23T05:15:34.098Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-analysis-alzheimers-clinical-trial-failures-2024 2026-05-23T05:15:29.392Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-clinical-trial-ethics-committees-analysis-2024 2026-05-23T05:15:26.394Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-analysis-biosimilars-us-inflation-reduction-act-2026 2026-05-23T05:15:24.396Z daily 0.7 https://novapharmanews.com/eu/articles/ema-hta-outcomes-oncology-drugs-eu-regulation-2024 2026-05-23T05:15:22.479Z daily 0.7 https://novapharmanews.com/us/articles/fda-adagrasib-phase3-trial-results-kras-g12c-nsclc-2024 2026-05-23T05:15:20.393Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-biosimilars-market-analysis-2026 2026-05-23T05:15:16.398Z daily 0.7 https://novapharmanews.com/eu/articles/ema-mhra-real-world-evidence-oncology-2024 2026-05-23T05:15:12.390Z daily 0.7 https://novapharmanews.com/eu/articles/g-ba-nice-hta-outcomes-oncology-therapies-2025 2026-05-23T05:15:10.387Z daily 0.7 https://novapharmanews.com/eu/articles/ema-clinical-trial-site-selection-qualification-requirements-2024 2026-05-23T05:15:08.388Z daily 0.7 https://novapharmanews.com/eu/articles/ema-pediatric-investigation-plans-oncology-2024 2026-05-23T05:15:02.401Z daily 0.7 https://novapharmanews.com/us/articles/sfda-accelerated-approval-anktiva-oncology-impact-2024 2026-05-23T05:14:58.382Z daily 0.7 https://novapharmanews.com/eu/articles/ema-regulatory-framework-european-biomarker-driven-trials-2024 2026-05-23T05:14:52.384Z daily 0.7 https://novapharmanews.com/eu/articles/ema-conditional-marketing-authorizations-oncology-2025 2026-05-23T05:14:44.385Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-data-integrity-foreign-pharma-impact-2026 2026-05-23T05:14:36.373Z daily 0.7 https://novapharmanews.com/us/articles/fda-analysis-novo-nordisk-semaglutide-alzheimers-failure-2025 2026-05-23T05:14:34.371Z daily 0.7 https://novapharmanews.com/eu/articles/ema-market-analysis-biosimilars-growth-eu-2024 2026-05-23T05:14:30.367Z daily 0.7 https://novapharmanews.com/eu/articles/ema-approval-novel-immunotherapies-advanced-melanoma-2026 2026-05-23T05:14:24.373Z daily 0.7 https://novapharmanews.com/us/articles/ama-progress-harmonizing-regulatory-standards-africa-2024 2026-05-23T09:52:43.297Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-pharmaceutical-legislation-reform-orphan-drug-2026 2026-05-23T17:14:23.531Z daily 0.7 https://novapharmanews.com/eu/articles/ema-conditional-approval-car-t-b-cell-lymphomas-2024 2026-05-23T05:15:46.405Z daily 0.7 https://novapharmanews.com/us/articles/fda-biosimilar-approval-pathway-regulatory-changes-2026 2026-05-23T05:15:48.406Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-analysis-teclistamab-bispecific-antibody-therapies-rrmm-2025 2026-05-23T06:32:35.344Z daily 0.7 https://novapharmanews.com/us/articles/fda-analysis-tirzepatide-surpass-cvot-cardiovascular-safety-2024 2026-05-23T05:15:52.395Z daily 0.7 https://novapharmanews.com/eu/articles/ema-impact-revised-eu-pharmaceutical-legislation-orphan-drug-2026 2026-05-23T16:27:17.785Z daily 0.7 https://novapharmanews.com/eu/articles/ema-conditional-approval-repotrectinib-oncology-2026 2026-05-23T05:15:56.392Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-analysis-bispecific-antibodies-hematological-malignancies-2025 2026-05-23T10:09:08.955Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-pembrolizumab-msi-high-solid-tumors-2024 2026-05-23T18:40:04.619Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-revnasiran-market-analysis-2024 2026-05-23T17:55:12.792Z daily 0.7 https://novapharmanews.com/apac/articles/pfizer-ai-strategy-pharma-innovation-dominance 2026-05-23T05:16:04.420Z daily 0.7 https://novapharmanews.com/apac/articles/ai-drug-discovery-patent-rankings-2025-deep-eigenmatics-leads 2026-05-23T05:16:06.417Z daily 0.7 https://novapharmanews.com/apac/articles/ai-driven-drug-discovery-partnership-merck-mayo-clinic 2026-05-23T05:16:08.398Z daily 0.7 https://novapharmanews.com/apac/articles/pharma-supercomputer-eli-lilly-nvidia-ai-drug-discovery 2026-05-23T05:16:10.496Z daily 0.7 https://novapharmanews.com/apac/articles/merck-mayo-clinic-ai-partnership-drug-discovery 2026-05-23T05:16:12.522Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-serialization-cancer-drug-supply-security-2024 2026-05-23T22:32:29.482Z daily 0.7 https://novapharmanews.com/us/articles/ama-implementation-regulatory-harmonization-pharma-access-2026 2026-05-23T05:16:16.529Z daily 0.7 https://novapharmanews.com/eu/articles/automation-eco-friendly-pharma-packaging 2026-05-23T14:47:09.127Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-approval-adcs-lung-cancer-trends-2025 2026-05-23T05:16:20.409Z daily 0.7 https://novapharmanews.com/eu/articles/ema-hta-trastuzumab-deruxtecan-eu-market-access-2025 2026-05-23T05:16:22.411Z daily 0.7 https://novapharmanews.com/us/articles/fda-breakthrough-therapy-designations-neurological-disorders-market-analysis-2026 2026-05-23T05:16:24.428Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-analysis-bispecific-antibody-therapies-b-cell-lymphomas-2024 2026-05-23T11:11:32.872Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-pembrolizumab-expanded-use-keynote-826-2024 2026-05-23T05:16:28.412Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-zongertinib-oncology-market-analysis-2026 2026-05-23T08:01:57.891Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-elarekibart-ailectra-attr-amyloidosis-2026 2026-05-23T11:41:37.560Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-regulatory-pathways-car-t-cell-therapy-japan-2024 2026-05-23T12:54:05.592Z daily 0.7 https://novapharmanews.com/us/articles/fda-labeling-changes-oral-semaglutide-cardiovascular-risk-2025 2026-05-23T20:05:01.380Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-sotorasib-adagrasib-kras-g12c-nsclc-2024 2026-05-23T05:16:38.547Z daily 0.7 https://novapharmanews.com/us/articles/fda-phase3-results-ensartinib-alk-nsclc-2024 2026-05-23T05:16:40.470Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-pembrolizumab-label-expansion-advanced-cervical-cancer-2024 2026-05-23T10:36:00.623Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-mresvia-mrna-vaccine-rsv-market-analysis-2024 2026-05-23T15:58:35.072Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-guideline-update-biosimilar-landscape-japan-2025 2026-05-23T05:16:46.515Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-pharmaceutical-legislation-reform-biosimilar-market-access-2025 2026-05-23T22:03:54.769Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-pharmaceutical-legislation-reform-generics-biosimilars-2026 2026-05-23T05:16:50.445Z daily 0.7 https://novapharmanews.com/eu/articles/ema-cross-border-healthcare-car-t-access-eu-policy-2024 2026-05-23T19:21:56.425Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-kras-g12c-inhibitors-nsclc-2024 2026-05-23T20:14:00.556Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-pembrolizumab-expanded-label-advanced-cervical-cancer-2024 2026-05-23T10:05:58.988Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-vx-009-oncodex-oncolytic-virus-therapy-2026 2026-05-23T05:16:58.423Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-accelerated-approval-oncology-innovative-drugs-2024 2026-05-23T18:55:30.590Z daily 0.7 https://novapharmanews.com/eu/articles/ema-implementation-clinical-trial-data-sharing-2024 2026-05-23T19:21:54.797Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-resvax-rsv-vaccine-market-analysis-2024 2026-05-23T23:30:15.940Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-biosimilars-approval-pathway-analysis-2025 2026-05-23T22:25:57.444Z daily 0.7 https://novapharmanews.com/us/articles/ama-impact-regulatory-harmonization-drug-access-2024 2026-05-23T05:17:08.454Z daily 0.7 https://novapharmanews.com/eu/articles/ema-safety-monitoring-phase-1-trial-evolution-2024 2026-05-23T22:29:21.374Z daily 0.7 https://novapharmanews.com/eu/articles/ema-guidelines-treatment-sequencing-advanced-nsclc-2024 2026-05-23T22:41:35.421Z daily 0.7 https://novapharmanews.com/eu/articles/ema-framework-cell-therapy-manufacturing-car-t-availability-2025 2026-05-23T15:53:01.188Z daily 0.7 https://novapharmanews.com/eu/articles/ema-revised-eu-pharmaceutical-legislation-biosimilar-market-entry-2027 2026-05-23T05:17:16.508Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-pharmaceutical-legislation-reform-orphan-drugs-2025 2026-05-23T19:53:23.363Z daily 0.7 https://novapharmanews.com/us/articles/fda-guidance-accelerated-approval-oncology-postmarket-2025 2026-05-23T20:50:02.548Z daily 0.7 https://novapharmanews.com/us/articles/fda-pipeline-analysis-next-generation-immunotherapy-2024 2026-05-23T05:17:22.555Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-sakigake-designation-expedited-drug-development-2026 2026-05-23T20:09:17.212Z daily 0.7 https://novapharmanews.com/us/articles/cofepris-approval-trends-new-drugs-2026 2026-05-23T07:21:02.807Z daily 0.7 https://novapharmanews.com/us/articles/fda-guidance-clinical-trial-transparency-results-reporting-2026 2026-05-23T20:45:14.104Z daily 0.7 https://novapharmanews.com/us/articles/nafdac-new-requirements-pediatric-clinical-trials-2024 2026-05-23T05:17:30.636Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-next-generation-sequencing-precision-oncology-mea-2024 2026-05-23T07:04:22.119Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-regulatory-update-biosimilar-market-growth-japan-2024 2026-05-23T21:14:10.569Z daily 0.7 https://novapharmanews.com/us/articles/fda-breakthrough-therapy-designation-rare-disease-market-analysis-2024 2026-05-23T05:59:36.953Z daily 0.7 https://novapharmanews.com/us/articles/fda-update-patritumab-deruxtecan-brain-metastasis-therapy-2024 2026-05-23T15:49:46.670Z daily 0.7 https://novapharmanews.com/us/articles/fda-updated-requirements-pediatric-clinical-trials-2024 2026-05-23T22:19:29.327Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-elarekig-treatment-resistant-depression-2024 2026-05-23T05:17:42.571Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-viruxa-oncolytic-virus-therapy-advanced-melanoma-2026 2026-05-23T05:17:44.639Z daily 0.7 https://novapharmanews.com/us/articles/fda-guidance-accelerated-approval-oncology-2024 2026-05-23T05:17:46.569Z daily 0.7 https://novapharmanews.com/us/articles/fda-evolving-rwe-framework-drug-approvals-2025 2026-05-23T12:57:00.667Z daily 0.7 https://novapharmanews.com/eu/articles/ema-fda-comparative-analysis-clinical-trial-protocols-2024 2026-05-23T05:17:50.659Z daily 0.7 https://novapharmanews.com/eu/articles/ema-market-access-egfr-inhibitors-launch-strategies-2024 2026-05-23T21:46:07.496Z daily 0.7 https://novapharmanews.com/eu/articles/ema-nice-gba-oncology-drug-market-analysis-2026 2026-05-23T12:51:22.687Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-integration-chinese-adcs-clinical-practice-2024 2026-05-23T05:17:56.570Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-regulatory-updates-biosimilar-landscape-japan-2025 2026-05-23T05:17:58.582Z daily 0.7 https://novapharmanews.com/us/articles/cofepris-approval-trends-fast-track-generics-2026 2026-05-23T14:47:42.160Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-biomarker-testing-brazil-oncology-market-2024 2026-05-23T05:18:02.594Z daily 0.7 https://novapharmanews.com/us/articles/pandrh-regulatory-harmonization-biosimilar-market-entry-latam-2026 2026-05-23T05:18:04.569Z daily 0.7 https://novapharmanews.com/us/articles/sfda-accelerated-approval-oncology-drugs-2024 2026-05-23T05:18:06.580Z daily 0.7 https://novapharmanews.com/us/articles/ppb-new-guidelines-research-site-certification-kenya-2026 2026-05-23T05:18:08.589Z daily 0.7 https://novapharmanews.com/us/articles/gcc-drug-guidelines-oncology-treatment-standardization-2024 2026-05-23T05:18:10.573Z daily 0.7 https://novapharmanews.com/us/articles/sfda-accelerated-drug-approval-saudi-pharmaceutical-market-2024 2026-05-23T05:18:12.579Z daily 0.7 https://novapharmanews.com/us/articles/gcc-dr-harmonization-pharmaceutical-market-access-2024 2026-05-23T07:27:20.742Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-elisrasib-apac-kras-inhibitors-2024 2026-05-23T05:26:13.313Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-sakigake-designation-cardiovascular-drug-approval-2024 2026-05-23T05:18:18.558Z daily 0.7 https://novapharmanews.com/eu/articles/ema-prac-safety-signal-bispecific-antibodies-hematologic-malignancies-2025 2026-05-23T05:18:20.599Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-report-small-molecule-vs-biologics-oncology-2024 2026-05-23T05:18:22.572Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-oncology-impact-2024 2026-05-23T05:18:24.582Z daily 0.7 https://novapharmanews.com/us/articles/fda-clinical-trial-protocol-amendments-impact-2024 2026-05-23T23:18:36.051Z daily 0.7 https://novapharmanews.com/us/articles/fda-cid-pilot-program-complex-innovative-trial-designs-2024 2026-05-23T14:26:39.465Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-elarekibart-xylantra-treatment-resistant-hypertension-2024 2026-05-23T17:23:54.453Z daily 0.7 https://novapharmanews.com/us/articles/fda-evolving-continuous-manufacturing-drug-quality-2024 2026-05-23T08:47:18.712Z daily 0.7 https://novapharmanews.com/eu/articles/ema-analysis-continuous-manufacturing-pharmaceuticals-2024 2026-05-23T05:18:34.589Z daily 0.7 https://novapharmanews.com/us/articles/fda-inflation-reduction-act-pharmaceutical-pricing-2024 2026-05-23T05:18:36.594Z daily 0.7 https://novapharmanews.com/us/articles/fda-evolving-stance-rwe-drug-development-2024 2026-05-23T20:44:13.522Z daily 0.7 https://novapharmanews.com/us/articles/fda-guidance-diversity-clinical-trials-2024 2026-05-23T05:18:40.586Z daily 0.7 https://novapharmanews.com/us/articles/fda-project-frontrunner-initiative-oncology-drug-reviews-2024 2026-05-23T20:49:35.349Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-oncology-trends-2026 2026-05-23T05:18:44.601Z daily 0.7 https://novapharmanews.com/us/articles/fda-guidelines-clinical-trial-site-selection-2025 2026-05-23T05:18:46.593Z daily 0.7 https://novapharmanews.com/us/articles/fda-commercial-analysis-us-oncology-biosimilar-landscape-2026 2026-05-23T05:18:48.604Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-oncology-market-access-2026 2026-05-23T12:56:22.674Z daily 0.7 https://novapharmanews.com/us/articles/fda-biosimilars-patent-expirations-market-analysis-2026 2026-05-23T05:18:52.616Z daily 0.7 https://novapharmanews.com/eu/articles/ema-analysis-european-academic-clinical-trials-funding-success-2024-2026 2026-05-23T05:18:54.599Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-approval-drugname-indication-market-analysis-2025 2026-05-23T05:18:56.587Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-guidelines-antibody-drug-conjugates-oncology-2025 2026-05-23T09:01:56.649Z daily 0.7 https://novapharmanews.com/us/articles/moh-uae-dubai-science-park-phase1-studies-2024 2026-05-23T05:19:00.611Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-accelerated-review-novel-cancer-therapies-2024 2026-05-23T05:19:02.594Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-antibody-drug-conjugates-pricing-access-mea-2024 2026-05-23T08:08:31.024Z daily 0.7 https://novapharmanews.com/us/articles/sfda-accelerated-drug-approval-saudi-pharma-market-2024 2026-05-23T05:19:06.590Z daily 0.7 https://novapharmanews.com/us/articles/ama-progress-harmonizing-drug-regulation-africa-2024 2026-05-23T08:34:16.302Z daily 0.7 https://novapharmanews.com/apac/articles/market-access-nmpa-177lu-psma-617-prostate-cancer-2024 2026-05-23T18:18:02.514Z daily 0.7 https://novapharmanews.com/eu/articles/nice-technology-appraisals-market-access-eu-2026 2026-05-23T05:19:12.600Z daily 0.7 https://novapharmanews.com/eu/articles/mhra-post-brexit-drug-approval-oncology-divergences-2024 2026-05-23T05:19:14.614Z daily 0.7 https://novapharmanews.com/us/articles/african-medicines-agency-impact-regulatory-harmonization-2024 2026-05-23T05:19:16.616Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-approval-lenacapavir-hiv-treatment-2025 2026-05-23T09:04:34.259Z daily 0.7 https://novapharmanews.com/us/articles/cofepris-biocomparables-pathway-biosimilars-mexico-2025 2026-05-23T07:22:44.879Z daily 0.7 https://novapharmanews.com/apac/articles/nmepa-priority-review-innovative-drug-approvals-2024 2026-05-23T17:15:04.367Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-regulatory-updates-sakigake-biosimilar-landscape-japan-2024 2026-05-23T05:19:25.225Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-pharmaceutical-legislation-reform-generic-biosimilar-2026-27 2026-05-23T23:27:48.564Z daily 0.7 https://novapharmanews.com/eu/articles/ema-accelerated-assessment-oncology-approval-timelines-2024 2026-05-23T05:19:28.601Z daily 0.7 https://novapharmanews.com/eu/articles/ema-conditional-approval-linvoseltamab-oncology-2026 2026-05-23T05:19:30.618Z daily 0.7 https://novapharmanews.com/us/articles/fda-safety-labeling-antidepressant-market-analysis-2026 2026-05-23T11:21:06.685Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-zongertinib-oncology-policy-2026 2026-05-23T23:31:27.145Z daily 0.7 https://novapharmanews.com/us/articles/african-medicines-agency-impact-multi-regional-clinical-trials-2025 2026-05-23T08:25:40.235Z daily 0.7 https://novapharmanews.com/us/articles/moh-uae-cancer-clinical-trials-hub-2024 2026-05-23T05:19:38.589Z daily 0.7 https://novapharmanews.com/us/articles/eda-local-manufacturing-generic-oncology-egypt-2024 2026-05-23T05:19:40.699Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-approval-lenacapavir-hiv-prevention-2025 2026-05-23T05:19:42.597Z daily 0.7 https://novapharmanews.com/apac/articles/tga-innovation-australian-biotech-solid-tumor-car-t-2024 2026-05-23T19:27:08.599Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-rebec-clinical-trial-registry-analysis-2024 2026-05-23T06:24:39.163Z daily 0.7 https://novapharmanews.com/eu/articles/ema-hta-car-t-therapies-cost-effectiveness-2024 2026-05-23T05:58:18.542Z daily 0.7 https://novapharmanews.com/eu/articles/mhra-post-brexit-regulatory-pathways-divergence-2024 2026-05-23T09:00:02.142Z daily 0.7 https://novapharmanews.com/us/articles/fda-breakthrough-therapy-designations-neurological-disorders-2026 2026-05-23T13:40:21.637Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-sotatercept-winrevair-pah-market-analysis-2024 2026-05-23T21:04:28.868Z daily 0.7 https://novapharmanews.com/us/articles/fda-clinical-trial-cost-analysis-phase1-3-2024 2026-05-23T21:55:33.730Z daily 0.7 https://novapharmanews.com/us/articles/cms-medicare-coverage-expansion-car-t-therapies-2024 2026-05-23T09:04:36.755Z daily 0.7 https://novapharmanews.com/eu/articles/ema-framework-real-world-evidence-hybrid-trial-designs-2024 2026-05-23T08:34:04.433Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-updated-biosimilar-interchangeability-guidelines-2024 2026-05-23T14:59:19.043Z daily 0.7 https://novapharmanews.com/eu/articles/ema-proposed-pharmaceutical-legislation-reform-orphan-drug-2024 2026-05-23T06:13:04.566Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-approval-accelerated-conditional-oncology-2024 2026-05-23T05:20:06.618Z daily 0.7 https://novapharmanews.com/apac/articles/hsa-clinical-trial-modernization-citds-2024 2026-05-23T06:09:52.814Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-oncology-policy-changes-2026 2026-05-23T22:42:58.888Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-accelerated-approval-innovative-drug-market-entry-2024 2026-05-23T05:20:12.620Z daily 0.7 https://novapharmanews.com/eu/articles/ema-hta-radioligand-therapy-prostate-cancer-2024 2026-05-23T22:32:25.179Z daily 0.7 https://novapharmanews.com/eu/articles/ema-chmp-positive-opinions-diabetes-drugs-q3-2026 2026-05-23T16:00:39.430Z daily 0.7 https://novapharmanews.com/us/articles/fda-phase3-data-checkpoint-inhibitor-combinations-melanoma-2024 2026-05-23T05:20:18.600Z daily 0.7 https://novapharmanews.com/eu/articles/ema-decision-biosimilar-pricing-oncology-2024 2026-05-23T09:54:57.017Z daily 0.7 https://novapharmanews.com/us/articles/fda-biosimilar-competition-impact-us-biologics-2026 2026-05-23T05:20:22.626Z daily 0.7 https://novapharmanews.com/us/articles/how-to-use-openfda-faers-responsibly 2026-05-23T15:57:24.516Z daily 0.7 https://novapharmanews.com/eu/articles/ema-prac-guidelines-drug-induced-liver-injury-2024 2026-05-23T13:54:16.887Z daily 0.7 https://novapharmanews.com/apac/articles/nmpla-expedited-approval-oncology-patient-access-2024 2026-05-23T21:54:28.741Z daily 0.7 https://novapharmanews.com/eu/articles/ema-comp-ai-rare-disease-drug-discovery-2024 2026-05-23T05:20:30.662Z daily 0.7 https://novapharmanews.com/us/articles/fda-telemedicine-pharmaceutical-access-adherence-2024 2026-05-23T05:20:32.629Z daily 0.7 https://novapharmanews.com/eu/articles/ema-integration-rwe-ehrs-regulatory-decisions-2024 2026-05-23T05:20:34.634Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-ai-drug-discovery-development-japan-2024 2026-05-23T15:36:56.895Z daily 0.7 https://novapharmanews.com/us/articles/fda-action-digital-health-innovation-samd-2024 2026-05-23T05:20:38.607Z daily 0.7 https://novapharmanews.com/us/articles/fda-ai-accelerating-drug-approvals-2024 2026-05-23T05:20:40.645Z daily 0.7 https://novapharmanews.com/us/articles/fda-blockchain-pharmaceutical-supply-chain-2024 2026-05-23T05:20:42.631Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-enzyme-replacement-therapy-gaucher-2024 2026-05-23T05:20:44.617Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-analysis-gene-therapies-sma-2024 2026-05-23T05:20:46.614Z daily 0.7 https://novapharmanews.com/us/articles/fda-regulatory-pathways-car-t-cell-therapy-advancements-2024 2026-05-23T18:35:49.776Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-gene-therapies-hemophilia-market-analysis-2024 2026-05-23T05:20:50.641Z daily 0.7 https://novapharmanews.com/us/articles/fda-breakthrough-therapy-designations-alzheimers-2024 2026-05-23T19:26:46.705Z daily 0.7 https://novapharmanews.com/us/articles/fda-master-protocols-platform-trials-development-2024 2026-05-23T06:05:49.497Z daily 0.7 https://novapharmanews.com/us/articles/fda-approved-kras-inhibitors-lung-cancer-2024 2026-05-23T17:05:57.158Z daily 0.7